You are here

COVID-19 vaccine safety monitoring plan

9 February 2021
Download COVID-19 vaccine safety monitoring plan


The aim of the COVID-19 Vaccine Safety Monitoring Plan is to strengthen the existing vaccine vigilance system for early detection and investigation of suspected side effects (also known as adverse events) following COVID-19 immunisation. This will enable the TGA to manage any emerging safety issues and help maintain public confidence in the immunisation program.

The key objectives of the COVID-19 Vaccine Safety Monitoring Plan are:

  1. timely collection and management of reports of COVID-19 vaccine adverse events following immunisation
  2. timely detection and investigation of COVID-19 vaccine safety signals
  3. timely action to address any COVID-19 vaccine safety concerns
  4. timely communications to inform the public of emerging COVID-19 vaccine safety information and to support public confidence in vaccines
  5. close collaboration and coordination of effort with other vaccine safety stakeholder groups.

We aim to provide documents in an accessible format. If you are having problems using a document with your accessibility tools, please contact us for help.